文献速递皮肤肿瘤

异时性基底细胞癌发生的预后模型

Occurrence of metachronous basal cell carcinomas: a prognostic model.
PubMed 文献 · Br J Dermatol · 2017-09-11

基于鹿特丹研究1077例首次基底细胞癌患者,采用Fine and Gray回归构建异时性基底细胞癌预后模型。

要点

  • 既往基底细胞癌诊断次数越多,新发风险越高
  • 诊断时多发病灶是异时性发生的强预测因素

核心结论

  • 既往基底细胞癌诊断日期数是异时性基底细胞癌的强预后因素,应纳入风险预测。
  • 结合其他易得特征构建的预后模型可识别新发基底细胞癌高风险患者。

研究设计与样本

  • 前瞻性人群队列研究(鹿特丹研究),纳入西北欧血统参与者1077例首次基底细胞癌患者。
  • 与荷兰病理登记库链接获取肿瘤数据,采用Fine and Gray回归分析竞争风险。
  • 使用bootstrapping校正患者内相关性和预测性能的统计乐观度。

主要发现

  • 既往异时性基底细胞癌越多,新发基底细胞癌风险越高。
  • 诊断时存在多于一个基底细胞癌是异时性基底细胞癌的另一强预测因素。

临床怎么用

  • 临床可依据既往基底细胞癌诊断次数和诊断时病灶数量评估异时性风险。
  • 预后模型有助于个体化制定 surveillance 策略,识别高风险患者。

局限性

  • 研究人群为西北欧血统,外推至其他人群需谨慎。
  • 原文未报告模型外部验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A third of patients with a first basal cell carcinoma (BCC) will develop subsequent (metachronous) BCCs. OBJECTIVES: To study the prognostic effect of the number of previous BCC diagnosis dates a patient has experienced to derive a prediction model to assess the risk of metachronous BCCs that may inform individualized decision making on surveillance. METHODS: We considered participants of north-western European ancestry from a prospective population-based cohort study (Rotterdam Study). After linkage with the Dutch Pathology Registry, 1077 patients with a first BCC were included. Candidate predictors for metachronous BCCs included patient, lifestyle and tumour characteristics. The prognostic model was developed with Fine and Gray regression analysis to account for competing risk of death. We used bootstrapping to correct for within-patient correlation and statistical optimism in predictive performance. RESULTS: Second to fifth BCCs occurred in 293, 122, 58 and 36 patients, with median follow-up times of 3·0, 2·1, 1·7 and 1·8 years after the previous BCC, respectively. The risk of a new BCC was higher for patients with more metachronous BCCs. Having more than one BCC at diagnosis was another strong predictor of metachronous BCCs. Discriminative ability of the model was reasonable with an optimism-corrected c-index of 0·70 at 3 years. CONCLUSIONS: The number of previous BCC diagnosis dates was a strong prognostic factor and should be considered when predicting the risk of metachronous BCCs. When the number of previous BCC diagnosis dates is combined with other readily available characteristics into a prognostic model, patients at high risk of a new BCC can be identified.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Smedinga H, Verkouteren JAC, Steyerberg EW, et al. Occurrence of metachronous basal cell carcinomas: a prognostic model. Br J Dermatol. 2017. PMID: 28664573. doi:10.1111/bjd.15771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。